JOHANNESBURG (AP) A two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron variant of the coronavirus, but 70% protection against hospitalization, according to a large-scale analysis in South Africa released Tuesday.The first large-scale analysis of vaccine effectiveness in the region where the new variant was discovered appears to